RecruitingNot ApplicableNCT05439161
XEN Glaucoma Gel Stent Versus Trabeculectomy
Multicentric Evaluation of Best Corrected Visual Acuity of the XEN Implant Versus Classic Trabeculectomy in Open Angle Glaucoma Subjects
Sponsor
Prof. Dr. Herbert Reitsamer
Enrollment
196 participants
Start Date
Dec 20, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
Multicentric evaluation of best corrected visual acuity of the XEN implant versus classic trabeculectomy in open angle glaucoma subjects
Eligibility
Min Age: 18 Years
Inclusion Criteria6
- Diagnosis of open angle glaucoma (Primary open angle glaucoma, Pseudoexfoliation glaucoma, Pigmentary dispersion glaucoma)
- Clinically eligible for both surgeries (Trabeculectomy and XEN) on the discretion of the surgeon (area of healthy, free and mobile conjunctiva in the superior nasal target quadrant)
- VA logMAR ≤ 1 (VA dec ≥ 0.1)
- Trabecular meshwork must be visible (with Shaffer angle grade \> 1 in the target quadrant)
- Age 18 years or older
- Patient understands the nature of the procedure, is willing to comply with associated follow-up evaluations, and provides written informed consent
Exclusion Criteria15
- Clinical significant cataract
- Subject has had prior cataract surgery in study eye ≤ 1 months (count to operation)
- Subject has had prior (incisional) glaucoma surgery (XEN, trabeculectomy, viscocanalostomy, canaloplasty, shunts of any type, collagen implants, etc.). Prior iridotomy is acceptable.
- Phacic Angle Closure Glaucoma
- Subject has neovascular, uveitic or angle recession glaucoma or any glaucoma associated with vascular disorders
- Active inflammation (e.g., blepharitis, conjunctivitis, keratitis, uveitis)
- Anterior chamber intraocular lens
- Vitreous present in the anterior chamber
- Presence of intraocular silicone oil
- History of corneal surgery, corneal opacities, or corneal disease
- Impaired episcleral venous drainage (e.g. Sturge-Weber or nanophthalmos)
- History of dermatologic keloid formation
- Active diabetic retinopathy, proliferative retinopathy, choroidal neovascularization, branch retinal vein occlusion, central retinal vein occlusion, or other ophthalmic disease or disorder that could confound study results
- Known or suspected allergy or sensitivity to drugs required for the surgical procedure or any of the device components (e.g., porcine products or glutaraldehyde),
- Pregnant or nursing women
Interventions
DEVICEsurgery
2 types of filtering glaucoma surgeries (classic trabeculectomy as gold standard, and newer XEN glaucoma microstent) are compared against each other in a prospective multicentric randomized study
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05439161
Related Trials
Transcorneal Electrical Stimulation for the Treatment of Visual Field Defects in Patients With Open-Angle Glaucoma
NCT066829621 location
Glaucoma Respsosne to Lifestyle Corrections in Sleep Apnea
NCT074470111 location
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
NCT0682273821 locations
DSLT for Reducing Medication in Glaucoma
NCT073908901 location
Clinical Study Evaluating the Safety and Performance of the MIST Device for Intraocular Pressure Reduction in Patients With Primary Open-Angle Glaucoma
NCT073586505 locations